2024
|
Invention
|
Methods of preventing on-target genotoxicity induced by nucleases. The CRISPR-Cas9 system has rev... |
2023
|
Invention
|
Use of nrf2 activators for the treatment of cerebral small vessel disease. Cerebral small vessel ... |
2021
|
Invention
|
3d bioprinting method for forming a cell specific tissue construct. in vitroin vitro tissue/organ... |
|
Invention
|
Methods for predicting acute severe colitis treatment response.
The present invention relates to... |
2020
|
Invention
|
An ubiquitin ligase inhibitor for use for preventing and/or treating a disease linked with cerebr... |
|
Invention
|
Use of mast cell stabilizer for the treatment of heart failure with preserved ejection fraction. ... |
|
Invention
|
Bcl-xl:fkbp12 fusion proteins suitable for screening agents capable of slowing down the aging pro... |
|
Invention
|
The double deamidated form of bcl-xl is a biomarker of platelet age.
Deamidation is usually view... |
|
Invention
|
The double deamidated form of bcl-xl is a biomarker of platelet age. Deamidation is usually viewe... |
2019
|
Invention
|
Methods of predicting the risk of having lower-extremity artery disease in patients suffering fro... |
2018
|
Invention
|
Use of fzd7 inhibitors for the treatment of retinal neovascularization. In vivoIn vivo intravitre... |
|
Invention
|
Methods and pharmaceutical compositions for reducing cd95- mediated cell motility.
The present i... |
|
Invention
|
Methods and pharmaceutical compositions for reducing cd95- mediated cell motility. The present in... |
2017
|
Invention
|
Pharmaceutical compositions for the treatment of endothelial dysfunction. Endothelial dysfunction... |
|
Invention
|
Methods for determining whether a patient suffering from a myeloproliferative neoplasm is at risk... |
|
Invention
|
Methods for predicting acute severe colitis treatment response. The present invention relates to ... |
2016
|
Invention
|
A method for quantifying bevacizumab. The present invention relates to the use of an Internal Sta... |
|
Invention
|
Methods and pharmaceutical compositions for the treatment of ebola virus disease. The invention r... |
2015
|
Invention
|
Methods and kits for predicting medically refractory acute severe colitis. The present invention ... |
2013
|
Invention
|
Matrix metalloproteinase 9 (mmp-9) aptamer and uses thereof.
The present invention relates to a ... |
|
Invention
|
Matrix metalloproteinase 9 (mmp-9) aptamer and uses thereof. The present invention relates to a n... |